Research Interests

1. Target drug resistance in breast cancer : Resistance mechanisms of target HER2 positive or estrogen receptor positive breast cancer therapy, including signaling pathways, EMT, and tumor microenvironment.

2. Individuzlized precision medicine : Integrating large clinical breast cancer patients cohort, clinicopathological features, multigene assays, and genomics data to predict treatment response and prognisis of breast cancer.